SCHEMBL2393357

SCHEMBL2393357

CCOC(=O)C(Cc1ccc(C(F)(F)F)cc1Oc1cccc(C#N)c1)C(=O)OCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 2/20 0.43
KDM4E B2RXH2 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
EPAS1 Q99814 5/20 0.40
CYP2C9 P11712 4/20 0.39
CYP1A2 P05177 3/20 0.39
CYP2C19 P33261 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
RECQL P46063 1/20 0.39
HTR2A P28223 2/20 0.39
SLC6A4 P31645 2/20 0.39
KCNH2 Q12809 2/20 0.39
VEGFA P15692 1/20 0.38
CNR2 P34972 1/20 0.38
MRGPRX4 Q96LA9 2/20 0.38
ELANE P08246 1/20 0.37
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
LRRK2 Q5S007 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4874724 0.89 PTGDR2 (0.48) PTGDR2EPAS1HTR2ASLC6A4KCNH2
SCHEMBL5574572 0.87 PTGDR2 (0.47) PTGDR2EPAS1HTR2ASLC6A4KCNH2
SCHEMBL5574574 0.84 PTGDR2 (0.45) PTGDR2EPAS1HTR2ASLC6A4KCNH2
SCHEMBL2398431 0.80 MRGPRX4 (0.46) PTGDR2EPAS1NPSR1HTR2ASLC6A4
SCHEMBL2393446 0.79 PPARG (0.47) PTGDR2EPAS1VEGFAMRGPRX4
SCHEMBL21223103 0.77 ALDH1A1 (0.43) SMN1; SMN2CYP2C9CYP1A2CYP2C19HTR2A
SCHEMBL2395800 0.76 EPAS1 (0.46) PTGDR2EPAS1NPSR1HTR2ASLC6A4
SCHEMBL27309402 0.75 ELANE (0.44) PTGDR2KDM4EHTTSMN1; SMN2CYP2C9
SCHEMBL5570087 0.73 EPAS1 (0.42) PTGDR2EPAS1HTR2ASLC6A4KCNH2
SCHEMBL2393359 0.73 PTGDR2 (0.46) PTGDR2KDM4EHTTSMN1; SMN2EPAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022248-B2 3-[2-(3-Cyanophenoxy)-4-(trifluoromethyl)phenyl]propanoic acid;prostaglandin D2 inhibitor, orphan receptor CRTH2 antagonist; antiinflammatory, analgesic, antipyretic; respiratory system disorders: asthma and rhinitis; coupling amino/thio-phenyl derivatives with ester followed by hydrolysis to acid ASTRAZENECA AB (SE) 2011-09-20 US disclosed